Pharmacological inhibition of p38 mitogen-activated protein kinases affects KC/CXCL1-induced intraluminal crawling, transendothelial migration, and chemotaxis of neutrophils in vivo

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Xu, Najia ^a   Hossain, Mokarram ^a   Liu, Lixin ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD11B ANTIGEN; CXCL1 CHEMOKINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; KETAMINE; PYRIDINE DERIVATIVE; XYLAZINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; DIAPEDESIS; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME INHIBITION; LEUKOCYTE ROLLING; MALE; MICROSCOPY; MICROVASCULATURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME LAPSE IMAGING; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UPREGULATION; VELOCITY; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MOUSE; NEUTROPHIL;

MURINAE;

ANIMALS; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOTAXIS, LEUKOCYTE; ENZYME INHIBITORS; IMIDAZOLES; KETAMINE; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; XYLAZINE;

EID: 84875654648     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/290565     Document Type: Article

References (49)

1. Kumar V., Sharma A., Neutrophils: Cinderella of innate immune system. International Immunopharmacology 2010 10 11 1325 1334 2-s2.0-77958152008 10.1016/j.intimp.2010.08.012
2. Phillipson M., Kubes P., The neutrophil in vascular inflammation. Nature Medicine 2011 17 1381 1390
3. Langer H. F., Chavakis T., Leukocyte-endothelial interactions in inflammation. Journal of Cellular and Molecular Medicine 2009 13 7 1211 1220 2-s2.0-68149162037 10.1111/j.1582-4934.2009.00811.x
4. Petri B., Phillipson M., Kubes P., The physiology of leukocyte recruitment: an in vivo perspective. Journal of Immunology 2008 180 10 6439 6446 2-s2.0-45549106551
5. Phillipson M., Heit B., Colarusso P., Liu L., Ballantyne C. M., Kubes P., Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. Journal of Experimental Medicine 2006 203 12 2569 2575 2-s2.0-33751525386 10.1084/jem.20060925 (Pubitemid 44833334)
6. Wojciechowski J. C., Sarelius I. H., Preferential binding of leukocytes to the endothelial junction region in venules in situ. Microcirculation 2005 12 4 349 359 2-s2.0-21044432539 10.1080/10739680590934763 (Pubitemid 40872927)
7. Phillipson M., Heit B., Parsons S. A., Petri B., Mullaly S. C., Colarusso P., Gower R. M., Neely G., Simon S. I., Kubes P., Vav1 is essential for mechanotactic crawling and migration of neutrophils out of the inflamed microvasculature. Journal of Immunology 2009 182 11 6870 6878 2-s2.0-67449155862 10.4049/jimmunol.0803414
8. Schenkel A. R., Mamdouh Z., Muller W. A., Locomotion of monocytes on endothelium is a critical step during extravasation. Nature Immunology 2004 5 4 393 400 2-s2.0-4544314167 10.1038/ni1051 (Pubitemid 38500088)
9. Yong H. Y., Koh M. S., Moon A., The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opinion on Investigational Drugs 2009 18 12 1893 1905 2-s2.0-72249120832 10.1517/13543780903321490
10. Cuenda A., Rousseau S., p38 MAP-Kinases pathway regulation, function and role in human diseases. Biochimica et Biophysica Acta 2007 1773 8 1358 1375 2-s2.0-34547154349 10.1016/j.bbamcr.2007.03.010 (Pubitemid 47125981)
11. Schindler J. F., Monahan J. B., Smith W. G., P38 pathway kinases as anti-inflammatory drug targets. Journal of Dental Research 2007 86 9 800 811 2-s2.0-34548800403 10.1177/154405910708600902
12. Haddad E. B., Birrell M., McCluskie K., Ling A., Webber S. E., Foster M. L., Belvisi M. G., Role of p38 MAP kinase in LPS-induced airway inflammation in the rat. British Journal of Pharmacology 2001 132 8 1715 1724 2-s2.0-0035039117 (Pubitemid 32397963)
13. Sweeney S. E., Firestein G. S., Signal transduction in rheumatoid arthritis. Current Opinion in Rheumatology 2004 16 3 231 237 2-s2.0-1942500129 10.1097/00002281-200405000-00011 (Pubitemid 38530491)
14. Hollenbach E., Neumann M., Vieth M., Roessner A., Malfertheiner P., Naumann M., Inhibition of p38 MAP kinase- and RICK/NF- B-signaling suppresses inflammatory bowel disease. The FASEB Journal 2004 18 13 1550 1552 2-s2.0-9444228220 10.1096/fj.04-1642fje (Pubitemid 39561629)
15. Legos J. J., Erhardt J. A., White R. F., Lenhard S. C., Chandra S., Parsons A. A., Tuma R. F., Barone F. C., SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Research 2001 892 1 70 77 2-s2.0-0035895803 10.1016/S0006-8993(00)03228-5 (Pubitemid 32126568)
16. Campbell J., Ciesielski C. J., Hunt A. E., Horwood N. J., Beech J. T., Hayes L. A., Denys A., Feldmann M., Brennan F. M., Foxwell B. M. J., A novel mechanism for TNF- α regulation by p38 MAPK: involvement of NF- B with implications for therapy in rheumatoid arthritis. Journal of Immunology 2004 173 11 6928 6937 2-s2.0-9144251043 (Pubitemid 39541081)
17. Jin N., Wang Q., Zhang X., Jiang D., Cheng H., Zhu K., The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus. International Immunopharmacology 2011 11 1319 1326
18. Lee J. C., Kumar S., Griswold D. E., Underwood D. C., Votta B. J., Adams J. L., Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000 47 2-3 185 201 2-s2.0-0034045949 10.1016/S0162-3109(00) 00206-X (Pubitemid 30394538)
19. Zu Y. L., Qi J., Gilchrist A., Fernandez G. A., Vazquez-Abad D., Kreutzer D. L., Huang C. K., Sha'afi R. I., p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF- α or FMLP stimulation. Journal of Immunology 1998 160 4 1982 1989 2-s2.0-0032519736 (Pubitemid 28106489)
20. Nick J. A., Avdi N. J., Gerwins P., Johnson G. L., Worthen G. S., Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. Journal of Immunology 1996 156 12 4867 4875 2-s2.0-0029967151 (Pubitemid 26174474)
21. Cara D. C., Kaur J., Forster M., McCafferty D. M., Kubes P., Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. Journal of Immunology 2001 167 11 6552 6558 2-s2.0-0035576199 (Pubitemid 33081591)
22. Lantos I., Bender P. E., Razgaitis K. A., Sutton B. M., DiMartino M. J., Griswold D. E., Walz D. T., Antiinflammatory activity of 5,6-diaryl-2,3- dihydroimidazo[2,1-b]thiazoles. Isomeric 4-pyridyl and 4-substituted phenyl derivatives. Journal of Medicinal Chemistry 1984 27 1 72 75 2-s2.0-0021350020 (Pubitemid 14176380)
23. Ben-Levy R., Hooper S., Wilson R., Paterson H. F., Marshall C. J., Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Current Biology 1998 8 19 1049 1057 2-s2.0-0032563807 (Pubitemid 28451029)
24. Xu N., Lei X., Liu L., Tracking neutrophil intraluminal crawling, transendothelial migration and chemotaxis in tissue by intravital video microscopy. The Journal of Visualized Experiments 2011 55 e3296 10.3791/3296
25. Lei X., Hossain M., Qadri S. M., Liu L., Different microvascular permeability responses elicited by the CXC chemokines MIP-2 and KC during leukocyte recruitment: role of LSP1. Biochemical and Biophysical Research Communications 2012 423 484 489
26. Liu L., Cara D. C., Kaur J., Raharjo E., Mullaly S. C., Jongstra-Bilen J., Jongstra J., Kubes P., LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. Journal of Experimental Medicine 2005 201 3 409 418 2-s2.0-13644270346 10.1084/jem.20040830 (Pubitemid 40229415)
27. Lieber J. G., Webb S., Suratt B. T., Young S. K., Johnson G. L., Keller G. M., Worthen G. S., The in vitro production and characterization of neutrophils from embryonic stem cells. Blood 2004 103 3 852 859 2-s2.0-1642500383 10.1182/blood-2003-04-1030 (Pubitemid 38129542)
28. Buschmann K., Koch L., Braach N., Mueller H., Frommhold D., Poeschl J., Ruef P., CXCL1-triggered interaction of LFA1 and ICAM1 control glucose-induced leukocyte recruitment during inflammation in vivo. Mediators of Inflammation 2012 2012 12 739176 10.1155/2012/739176
29. Kaur J., Woodman R. C., Kubes P., P38 MAPK: critical molecule in thrombin-induced NF- B-dependent leukocyte recruitment. American Journal of Physiology 2003 284 4 H1095 H1103 2-s2.0-0037377552 (Pubitemid 36348570)
30. Marin V., Farnarier C., Grès S., Kaplanski S., Su M. S. S., Dinarello C. A., The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment. Blood 2001 98 3 667 673 2-s2.0-0035437126 10.1182/blood.V98.3.667
31. El-Shazly A. E., Moonen V., Mawet M., Begon D., Henket M., Arafa M., Louis R., Delvenne P., Lefebvre P. P., IFN- γ and TNF- α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. International Immunopharmacology 2011 11 1864 1870
32. Birrell M. A., Wong S., McCluskie K., Catley M. C., Hardaker E. L., Haj-Yahia S., Belvisi M. G., Second-generation inhibitors demonstrate the involvement of p38 mitogen-activated protein kinase in post-transcriptional modulation of inflammatory mediator production in human and rodent airways. Journal of Pharmacology and Experimental Therapeutics 2006 316 3 1318 1327 2-s2.0-33644787093 10.1124/jpet.105.093310 (Pubitemid 43345308)
33. Geest C. R., Buitenhuis M., Laarhoven A. G., Bierings M. B., Bruin M. C. A., Vellenga E., Coffer P. J., p38 MAP kinase inhibits neutrophil development through phosphorylation of C/EBP α on serine 21. Stem Cells 2009 27 9 2271 2282 2-s2.0-70349865008 10.1002/stem.152
34. Menon M. B., Kotlyarov A., Gaestel M., SB202190-induced cell type-specific vacuole formation and defective autophagy do not depend on p38 MAP kinase inhibition. PLoS One 2011 6 e23054
35. Henklova P., Vrzal R., Papouskova B., Bednar P., Jancova P., Anzenbacherova E., Ulrichova J., Maurel P., Pavek P., Dvorak Z., SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes. European Journal of Pharmacology 2008 593 1-3 16 23 2-s2.0-49949102064 10.1016/j.ejphar.2008.07. 007
36. Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R., Lee J. C., SE 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Letters 1995 364 2 229 233 2-s2.0-0028988138 10.1016/0014-5793(95)00357-F
37. Detmers P. A., Zhou D., Polizzi E., Thieringer R., Hanlon W. A., Vaidya S., Bansal V., Role of stress-activated mitogen-activated protein kinase (p38) in β 2- integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. Journal of Immunology 1998 161 4 1921 1929 2-s2.0-0032529398 (Pubitemid 28387615)
38. Eckert R. E., Sharief Y., Jones S. L., p38 mitogen-activated kinase (MAPK) is essential for equine neutrophil migration. Veterinary Immunology and Immunopathology 2009 129 3-4 181 191 2-s2.0-64749093057 10.1016/j.vetimm.2008. 11.007
39. Pan S. L., Tao K. Y., Guh J. H., Sun H. L., Huang D. Y., Chang Y. L., Teng C. M., The p38 mitogen-activated protein kinase pathway plays a critical role in PAR2-induced endothelial IL-8 production and leukocyte adhesion. Shock 2008 30 5 496 502 2-s2.0-55949105842 10.1097/SHK.0b013e3181673233
40. Santén S., Mihaescu A., Laschke M. W., Menger M. D., Wang Y., Jeppsson B., Thorlacius H., p38 MAPK regulates ischemia-reperfusion-induced recruitment of leukocytes in the colon. Surgery 2009 145 3 303 312 2-s2.0-60149086844 10.1016/j.surg.2008.10.011
41. Tandon R., Sha'afi R. I., Thrall R. S., Neutrophil β 2-integrin upregulation is blocked by a p38 MAP kinase inhibitor. Biochemical and Biophysical Research Communications 2000 270 3 858 862 2-s2.0-0034696703 10.1006/bbrc.2000.2540 (Pubitemid 30444797)
42. Hepper I., Schymeinsky J., Weckbach L. T., Jakob S. M., Frommhold D., Sixt M., Laschinger M., Sperandio M., Walzog B., The mammalian actin-binding protein 1 is critical for spreading and intraluminal crawling of neutrophils under flow conditions. The Journal of Immunology 2012 188 4590 4601
43. Schymeinsky J., Sindrilaru A., Frommhold D., Sperandio M., Gerstl R., Then C., Mócsai A., Scharffetter-Kochanek K., Walzog B., The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for β 2 integrin (CD11/CD18)-mediated neutrophil migration. Blood 2006 108 12 3919 3927 2-s2.0-33845268014 10.1182/blood-2005-12-030387 (Pubitemid 44864578)
44. Ryan J., Ma F. Y., Kanellis J., Delgado M., Blease K., Nikolic-Paterson D. J., Spleen tyrosine kinase promotes acute neutrophil-mediated glomerular injury via activation of JNK and p38 MAPK in rat nephrotoxic serum nephritis. Laboratory Investigation 2011 91 1727 1738
45. Kogut M., Lowry V. K., Farnell M., Selective pharmacological inhibitors reveal the role of Syk tyrosine kinase, phospholipase C, phosphatidylinositol- 3′-kinase, and p38 mitogen-activated protein kinase in Fc receptor-mediated signaling of chicken heterophil degranulation. International Immunopharmacology 2002 2 7 963 973 2-s2.0-0036317844 10.1016/S1567-5769(02) 00050-4 (Pubitemid 34756387)
46. Frevert C. W., Huang S., Danaee H., Paulauskis J. D., Kobzik L., Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. Journal of Immunology 1995 154 1 335 344 2-s2.0-0028809048
47. Heit B., Colarusso P., Kubes P., Fundamentally different roles for LFA-1, Mac-1 and α 4-integrin in neutrophil chemotaxis. Journal of Cell Science 2005 118 22 5205 5220 2-s2.0-29244459407 10.1242/jcs.02632 (Pubitemid 41819584)
48. Montecucco F., Steffens S., Burger F., Da Costa A., Bianchi G., Bertolotto M., Mach F., Dallegri F., Ottonello L., Tumor necrosis factor-alpha (TNF- α) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1 α) on human neutrophils through defined signalling pathways. Cellular Signalling 2008 20 3 557 568 2-s2.0-38349025503 10.1016/j.cellsig.2007.11.008
49. Zhang S., Rahman M., Zhang S., Wang Y., Herwald H., Jeppsson B., Thorlacius H., p38 Mitogen-activated protein kinase signaling regulates streptococcal M1 protein-induced neutrophil activation and lung injury. Journal of Leukocyte Biology 2012 91 137 145